Exploring kinase inhibitors as therapies for human arenavirus infections

Eric M. Vela, Gavin C. Bowick, Norbert K. Herzog, Judith Aronson

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Arenaviruses are rodent-borne RNA viruses, and some have the capacity to cause hemorrhagic fever and death in infected individuals and thus have been identified as a potential bioterrorism threat. Ribavirin and supportive care are currently the approved therapeutic options for individuals suffering from arenavirus-induced hemorrhagic fever. However, new research has suggested that immune plasma treatment or kinase inhibitors may provide a therapeutic option for treating arenavirus infections in humans. This article puts forth a perspective as to the potential use of kinase inhibitors as an antiviral therapeutic for arenavirus infections.

Original languageEnglish (US)
Pages (from-to)243-251
Number of pages9
JournalFuture Virology
Volume3
Issue number3
DOIs
StatePublished - May 2008

Fingerprint

Arenaviridae Infections
Arenavirus
Phosphotransferases
Fever
Bioterrorism
Ribavirin
RNA Viruses
Antiviral Agents
Therapeutics
Research

Keywords

  • Antiviral therapeutics
  • Arenavirus
  • Hemorrhagic fever
  • Kinase inhibitors
  • Virology

ASJC Scopus subject areas

  • Virology

Cite this

Exploring kinase inhibitors as therapies for human arenavirus infections. / Vela, Eric M.; Bowick, Gavin C.; Herzog, Norbert K.; Aronson, Judith.

In: Future Virology, Vol. 3, No. 3, 05.2008, p. 243-251.

Research output: Contribution to journalArticle

Vela, Eric M. ; Bowick, Gavin C. ; Herzog, Norbert K. ; Aronson, Judith. / Exploring kinase inhibitors as therapies for human arenavirus infections. In: Future Virology. 2008 ; Vol. 3, No. 3. pp. 243-251.
@article{1170330eeb0b430d9dac201a31b1cc33,
title = "Exploring kinase inhibitors as therapies for human arenavirus infections",
abstract = "Arenaviruses are rodent-borne RNA viruses, and some have the capacity to cause hemorrhagic fever and death in infected individuals and thus have been identified as a potential bioterrorism threat. Ribavirin and supportive care are currently the approved therapeutic options for individuals suffering from arenavirus-induced hemorrhagic fever. However, new research has suggested that immune plasma treatment or kinase inhibitors may provide a therapeutic option for treating arenavirus infections in humans. This article puts forth a perspective as to the potential use of kinase inhibitors as an antiviral therapeutic for arenavirus infections.",
keywords = "Antiviral therapeutics, Arenavirus, Hemorrhagic fever, Kinase inhibitors, Virology",
author = "Vela, {Eric M.} and Bowick, {Gavin C.} and Herzog, {Norbert K.} and Judith Aronson",
year = "2008",
month = "5",
doi = "10.2217/17460794.3.3.243",
language = "English (US)",
volume = "3",
pages = "243--251",
journal = "Future Virology",
issn = "1746-0794",
publisher = "Future Medicine Ltd.",
number = "3",

}

TY - JOUR

T1 - Exploring kinase inhibitors as therapies for human arenavirus infections

AU - Vela, Eric M.

AU - Bowick, Gavin C.

AU - Herzog, Norbert K.

AU - Aronson, Judith

PY - 2008/5

Y1 - 2008/5

N2 - Arenaviruses are rodent-borne RNA viruses, and some have the capacity to cause hemorrhagic fever and death in infected individuals and thus have been identified as a potential bioterrorism threat. Ribavirin and supportive care are currently the approved therapeutic options for individuals suffering from arenavirus-induced hemorrhagic fever. However, new research has suggested that immune plasma treatment or kinase inhibitors may provide a therapeutic option for treating arenavirus infections in humans. This article puts forth a perspective as to the potential use of kinase inhibitors as an antiviral therapeutic for arenavirus infections.

AB - Arenaviruses are rodent-borne RNA viruses, and some have the capacity to cause hemorrhagic fever and death in infected individuals and thus have been identified as a potential bioterrorism threat. Ribavirin and supportive care are currently the approved therapeutic options for individuals suffering from arenavirus-induced hemorrhagic fever. However, new research has suggested that immune plasma treatment or kinase inhibitors may provide a therapeutic option for treating arenavirus infections in humans. This article puts forth a perspective as to the potential use of kinase inhibitors as an antiviral therapeutic for arenavirus infections.

KW - Antiviral therapeutics

KW - Arenavirus

KW - Hemorrhagic fever

KW - Kinase inhibitors

KW - Virology

UR - http://www.scopus.com/inward/record.url?scp=44149088837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44149088837&partnerID=8YFLogxK

U2 - 10.2217/17460794.3.3.243

DO - 10.2217/17460794.3.3.243

M3 - Article

AN - SCOPUS:44149088837

VL - 3

SP - 243

EP - 251

JO - Future Virology

JF - Future Virology

SN - 1746-0794

IS - 3

ER -